Overweight and obesity status causes nearly half a million new cancer cases each year
the ONA take:
According to a new study published in the journal The Lancet Oncology, researchers from the International Agency for Research on Cancer have found that nearly half a million new cases of cancer each year are a result of high body mass index (BMI).
For the study, researchers analyzed data from 2012 and found that 3.6% of all new cancer cases are associated with high BMI. In addition, they found that cancer linked with being overweight or obese is much more common in developed countries compared with less developed countries. North America had the highest rate of overweight and obesity-related cancer; of all BMI-related cancer cases across the globe, 23% occur in North America.
Results showed that Europe too has a large BMI-related cancer burden, particularly in Eastern Europe where 6.5% of all new cancer cases in Europe occurred there. China contributes 50,000 BMI-related cancer cases each year. On the other hand, Africa only had 1.5% of BMI-related new cancer cases in 2012.
Furthermore, women were found to more likely develop BMI-related cancer than men (5.3% of BMI-linked new cancer cases versus 1.9%). The most common BMI-related cancers in women were endometrium, colon, and breast, while kidney and colon were the most common BMI-linked cancer in men.
Nearly half a million new cases of cancer each year are a result of high BMI.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|